Xeris Biopharma Holdings, Inc. (XERS)
NASDAQ·Healthcare·Biotechnology
$6.84
-0.94%
Mkt Cap $1.17B
Analyst Ratings
Buy
2
Hold
0
Sell
0
Price Target (7 analysts)
$9.00
Range $9.00 – $9.00
Implied Upside
+31.7%
Consensus $9.00 vs current $6.84
NASDAQ·Healthcare·Biotechnology
$6.84
-0.94%
Mkt Cap $1.17B
Buy
2
Hold
0
Sell
0
Price Target (7 analysts)
$9.00
Range $9.00 – $9.00
+31.7%
Consensus $9.00 vs current $6.84